Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Assessment of rebound in cancer diagnoses in California in 2022, by stage, sociodemographic factors, and rurality.
Erin L Van Blarigan, Alison J Canchola, Li Zhu, Salma Shariff-Marco, Mindy C DeRouen, Iona Cheng, Meg McKinley, Debora L Oh, Katherine Lin, Scarlett Lin Gomez
Published: 202510.1158/1055-9965.EPI-25-1246
Abstract
BACKGROUND: The reduction in cancer cases in 2020 has been attributed to missed diagnoses during the pandemic, yet no rebound occurred in 2021. We examined whether cancer rebounded in California in 2022. METHODS: Data on invasive tumors in California…
Preview only. Read the full abstract at the source